TransMedics Group (TMDX) Metrics: History & Chart

TransMedics Group, Inc.(TMDX)

Medical - Devices · Andover, MA

$86.42-0.24 (-0.28%)

Delayed quote: Sep 18, 2026, 4:00 PM EDT

About TransMedics Group, Inc.

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.

Andover, MA

898 employees

www.transmedics.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Waleed H. Hassanein

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-8.67%
30D Total Return	-5.56%
YTD Total Return	-32.45%
1Y Total Return	-29.75%
3Y Total Return	+38.02%
5Y Total Return	+158.84%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-32.45%
2025	+95.11%
2024	-21.01%
2023	+27.88%
2022	+222.13%
2021	-3.72%
2020

CAGR TTM	-29.77%
CAGR 3Y	+11.34%
CAGR 5Y	+20.95%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	21.29
PE Ratio Avg TTM	36.33
PE Ratio Avg 3Y	55.70
Current VS TTM Avg	-41.40%
Current VS 3Y Avg	-61.78%
Current VS 5Y Avg	-61.78%

All Metrics

TMDX Valuation Metrics

TMDX Stock Price Metrics

TMDX Dividend Metrics

TMDX Growth Rate Metrics

TMDX Discounted Cash Flow Metrics

TMDX Returns By Period

TMDX Yearly Returns

TMDX Average Annual Returns By Period (CAGR)

TMDX Revenue Metrics

TMDX PE Ratio Metrics

TMDX PS Ratio Metrics

TMDX PB Ratio Metrics

TMDX Price to Free Cash Flow Ratio Metrics

TMDX Debt to Equity Ratio Metrics

TMDX PEG Ratio Metrics

TMDX FCF Yield

TMDX Earnings Yield

TMDX EBITDA Yield

TMDX OCF Yield

TMDX EV/EBIT Ratio Metrics

TMDX EV/EBITDA Ratio Metrics

TMDX EV/Assets Ratio Metrics

TMDX EV/Sales Ratio Metrics

TMDX Current Ratio Metrics

TMDX Quick Ratio Metrics

TMDX ROIC Metrics

TMDX Return on Assets Metrics

TMDX Return on Equity Metrics

TMDX Net Profit Margin Metrics

TMDX Gross Profit Margin Metrics

TMDX Tax Rate Metrics

PS Ratio	5.00
PS Ratio Avg TTM	7.32
PS Ratio Avg 3Y	9.85
Current VS TTM Avg	-31.71%
Current VS 3Y Avg	-49.24%
Current VS 5Y Avg	-66.80%

PB Ratio	6.46
PB Ratio Avg TTM	10.81
PB Ratio Avg 3Y	16.38
Current VS TTM Avg	-40.24%
Current VS 3Y Avg	-60.56%
Current VS 5Y Avg	-56.13%

PFCF Ratio	42.33
PFCF Ratio Avg TTM	34.72
PFCF Ratio Avg 3Y	34.72
Current VS TTM Avg	+21.93%
Current VS 3Y Avg	+21.93%
Current VS 5Y Avg	+21.93%

Debt/Equity Ratio	1.67
Debt/Equity Ratio Avg TTM	1.50
Debt/Equity Ratio Avg 3Y	2.43
Current VS TTM Avg	+11.54%
Current VS 3Y Avg	-30.95%
Current VS 5Y Avg	-1.54%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.36%
FCF Yield Avg TTM	2.14%
FCF Yield Avg 3Y	1.84%
Current VS TTM Avg	+10.17%
Current VS 3Y Avg	+28.60%
Current VS 5Y Avg	+28.60%

Earnings Yield	4.70%
Earnings Yield Avg TTM	3.63%
Earnings Yield Avg 3Y	2.26%
Current VS TTM Avg	+29.59%
Current VS 3Y Avg	+107.65%
Current VS 5Y Avg	+107.65%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	45.84
Ev/Ebit Ratio Avg TTM	48.09
Ev/Ebit Ratio Avg 3Y	65.08
Current VS TTM Avg	-4.67%
Current VS 3Y Avg	-29.56%
Current VS 5Y Avg	-29.56%

Ev/Ebitda Ratio	31.69
Ev/Ebitda Ratio Avg TTM	36.95
Ev/Ebitda Ratio Avg 3Y	46.38
Current VS TTM Avg	-14.25%
Current VS 3Y Avg	-31.67%
Current VS 5Y Avg	-31.67%

Ev/Assets Ratio	2.55
Ev/Assets Ratio Avg TTM	4.23
Ev/Assets Ratio Avg 3Y	4.62
Current VS TTM Avg	-39.65%
Current VS 3Y Avg	-44.83%
Current VS 5Y Avg	-52.39%

Ev/Sales Ratio	5.60
Ev/Sales Ratio Avg TTM	7.59
Ev/Sales Ratio Avg 3Y	10.19
Current VS TTM Avg	-26.27%
Current VS 3Y Avg	-45.05%
Current VS 5Y Avg	-63.02%

Current Ratio	6.62
Current Ratio Avg TTM	7.61
Current Ratio Avg 3Y	8.58
Current VS TTM Avg	-12.94%
Current VS 3Y Avg	-22.80%
Current VS 5Y Avg	-20.30%

Quick Ratio	6.07
Quick Ratio Avg TTM	7.03
Quick Ratio Avg 3Y	7.85
Current VS TTM Avg	-13.63%
Current VS 3Y Avg	-22.62%
Current VS 5Y Avg	-19.46%

ROIC	5.87%
ROIC Avg 3Y	3.42%
ROIC Avg 5Y	(7.70%)
Current VS 3Y Avg	+71.58%
Current VS 5Y Avg	+176.24%
Current VS 10Y Avg	+132.28%

ROA	10.36%
ROA Avg TTM	3.57%
ROA Avg 3Y	1.47%
Current VS TTM Avg	+189.92%
Current VS 3Y Avg	+604.45%
Current VS 5Y Avg	+634.51%

ROE	29.28%
ROE Avg TTM	30.53%
ROE Avg 3Y	10.66%
Current VS TTM Avg	-4.11%
Current VS 3Y Avg	+174.80%
Current VS 5Y Avg	+359.50%

Net Profit Margin	22.69%
Net Profit Margin Avg TTM	23.32%
Net Profit Margin Avg 3Y	9.52%
Current VS TTM Avg	-2.68%
Current VS 3Y Avg	+138.27%
Current VS 5Y Avg	+963.37%

Gross Profit Margin	58.69%
Gross Pft Margin Avg TTM	59.21%
Gross Pft Margin Avg 3Y	59.60%
Current VS TTM Avg	-0.88%
Current VS 3Y Avg	-1.53%
Current VS 5Y Avg	-8.57%

Tax Rate	24.34%
Tax Rate Avg 3Y	(31.63%)
Tax Rate Avg 5Y	(31.63%)
Current VS 3Y Avg	+176.96%
Current VS 5Y Avg	+176.96%
Current VS 10Y Avg	+176.96%